[go: up one dir, main page]

GB201720425D0 - CD47 and CD33 antigen-binding molecules - Google Patents

CD47 and CD33 antigen-binding molecules

Info

Publication number
GB201720425D0
GB201720425D0 GBGB1720425.6A GB201720425A GB201720425D0 GB 201720425 D0 GB201720425 D0 GB 201720425D0 GB 201720425 A GB201720425 A GB 201720425A GB 201720425 D0 GB201720425 D0 GB 201720425D0
Authority
GB
United Kingdom
Prior art keywords
antigen
binding molecules
molecules
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1720425.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hummingbird Bioscience Holdings Ltd
Original Assignee
Hummingbird Bioscience Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hummingbird Bioscience Holdings Ltd filed Critical Hummingbird Bioscience Holdings Ltd
Priority to GBGB1720425.6A priority Critical patent/GB201720425D0/en
Publication of GB201720425D0 publication Critical patent/GB201720425D0/en
Priority to CN201880071849.4A priority patent/CN111417653A/en
Priority to PCT/EP2018/079933 priority patent/WO2019086574A1/en
Priority to PCT/EP2018/079931 priority patent/WO2019086573A1/en
Priority to KR1020207014915A priority patent/KR20200079511A/en
Priority to JP2020543394A priority patent/JP2021500926A/en
Priority to SG11202003943YA priority patent/SG11202003943YA/en
Priority to EP18803566.1A priority patent/EP3704157A1/en
Priority to CA3080860A priority patent/CA3080860A1/en
Priority to AU2018358004A priority patent/AU2018358004A1/en
Priority to US16/760,899 priority patent/US20220298254A1/en
Priority to US17/847,020 priority patent/US11685789B2/en
Ceased legal-status Critical Current

Links

GBGB1720425.6A 2017-11-01 2017-12-07 CD47 and CD33 antigen-binding molecules Ceased GB201720425D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB1720425.6A GB201720425D0 (en) 2017-12-07 2017-12-07 CD47 and CD33 antigen-binding molecules
US16/760,899 US20220298254A1 (en) 2017-11-01 2018-11-01 Cd47 antigen-binding molecules
KR1020207014915A KR20200079511A (en) 2017-11-01 2018-11-01 CD47 antigen-binding molecule
PCT/EP2018/079933 WO2019086574A1 (en) 2017-11-01 2018-11-01 Cd47 and cd33 antigen-binding molecules
PCT/EP2018/079931 WO2019086573A1 (en) 2017-11-01 2018-11-01 Cd47 antigen-binding molecules
CN201880071849.4A CN111417653A (en) 2017-11-01 2018-11-01 CD47 antigen binding molecule
JP2020543394A JP2021500926A (en) 2017-11-01 2018-11-01 CD47 antigen-binding molecule
SG11202003943YA SG11202003943YA (en) 2017-11-01 2018-11-01 Cd47 antigen-binding molecules
EP18803566.1A EP3704157A1 (en) 2017-11-01 2018-11-01 Cd47 antigen-binding molecules
CA3080860A CA3080860A1 (en) 2017-11-01 2018-11-01 Cd47 antigen-binding molecules
AU2018358004A AU2018358004A1 (en) 2017-11-01 2018-11-01 CD47 antigen-binding molecules
US17/847,020 US11685789B2 (en) 2017-11-01 2022-06-22 CD47 antigen-binding molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1720425.6A GB201720425D0 (en) 2017-12-07 2017-12-07 CD47 and CD33 antigen-binding molecules

Publications (1)

Publication Number Publication Date
GB201720425D0 true GB201720425D0 (en) 2018-01-24

Family

ID=61007165

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1720425.6A Ceased GB201720425D0 (en) 2017-11-01 2017-12-07 CD47 and CD33 antigen-binding molecules

Country Status (1)

Country Link
GB (1) GB201720425D0 (en)

Similar Documents

Publication Publication Date Title
SG11202003943YA (en) Cd47 antigen-binding molecules
IL269534A (en) Chimeric molecules and uses thereof
IL268828A (en) products and vehicles
IL264970A (en) Anti-tim-3 antibodies and use thereof
IL260937A (en) Fabs-in-tandem immunoglobulin and uses thereof
IL257324A (en) Antibody against glypican-3 and application thereof
SG11202000053TA (en) Anti-cd47 antibodies and uses thereof
LT3274370T (en) ANTIBODIES AGAINST CEACAM6 AND THEIR USE
DK3265575T3 (en) CD20 BINDING MOLECULES AND USES THEREOF
DK3164159T3 (en) BISPECIFIC CD33 AND CD3 BINDING PROTEINS
SG11201607143UA (en) Anti sirp-alpha antibodies and bi-specific macrophage enhancing antibodies
SG10201912366YA (en) Anti-cd3 antibody and molecules comprising the antibody
EP3422617A4 (en) SIGNAL TRANSMISSION PROCESS AND DEVICE
PL3329167T3 (en) Line element having an inner element and an outer element
SG11202004897XA (en) Polypeptide including antigen-binding domain and carrying section
ZA201806597B (en) Ilt7 binding molecules and methods of using the same
GB201503812D0 (en) Antibody molecules and uses thereof
HUE051824T2 (en) Torque-sensing device and vehicle
DK3100886T3 (en) VEHICLE AND TRANSMISSION SYSTEM THEREOF
IL270719A (en) Biopharmaceutical compounds and related methods
DK3417058T3 (en) Sortase-modified molecules and their uses
IL263242A (en) Cytosol-penetrating antibody and use thereof
GB201719555D0 (en) Biosensor device and assembly methods
IL278832A (en) Optimized gp41-binding molecules and uses thereof
IL266721A (en) Anti-gp73 antibodies and immunoconjugates

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)